|
ZNF33B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.891850E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.734000E-02 |
| Normal-vs-Stage2 |
7.721600E-01 |
| Normal-vs-Stage3 |
2.525000E-01 |
| Normal-vs-Stage4 |
6.800400E-01 |
| Stage1-vs-Stage2 |
5.753200E-01 |
| Stage1-vs-Stage3 |
7.077600E-01 |
| Stage1-vs-Stage4 |
2.283800E-01 |
| Stage2-vs-Stage3 |
5.497000E-01 |
| Stage2-vs-Stage4 |
5.873000E-01 |
| Stage3-vs-Stage4 |
3.112600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.216200E-01 |
| Normal-vs-AfricanAmerican |
6.670200E-01 |
| Normal-vs-Asian |
5.082800E-01 |
| Caucasian-vs-AfricanAmerican |
6.539600E-01 |
| Caucasian-vs-Asian |
7.507200E-01 |
| AfricanAmerican-vs-Asian |
6.587000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.968100E-02 |
| Normal-vs-Female |
9.963200E-01 |
| Male-vs-Female |
1.627180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.448640E-01 |
| Normal-vs-Extreme_Weight |
1.544370E-02 |
| Normal-vs-Obese |
9.883200E-01 |
| Normal-vs-Extreme_Obese |
2.343400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.121200E-01 |
| Normal_Weight-vs-Obese |
2.213800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.739200E-01 |
| Extreme_Weight-vs-Obese |
5.405600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.679800E-01 |
| Obese-vs-Extreme_Obese |
3.854000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.013200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.601200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.179500E-02 |
| Normal-vs-Age(81-100Yrs) |
6.569900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.040800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.389200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.860200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.099620E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.964400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.037800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.623800E-01 |
| Normal-VS-Type2 PRCC |
2.701700E-03 |
| Normal-VS-KIRP CIMP |
1.407830E-01 |
| Normal-VS-Unclassified PRCC |
4.684600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.724900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.076400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.497800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.599200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.329600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.831410E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.079520E-02 |
| Normal-vs-N1 |
9.914200E-01 |
| Normal-vs-N2 |
9.877300E-03 |
| N0-vs-N1 |
1.581820E-01 |
| N0-vs-N2 |
3.554600E-01 |
| N1-vs-N2 |
2.138400E-01 |
|
|
